CLL and Non-Hodgkin Lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib
CLL and non-hodgkin lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib
Author: cancergrace
Added: 06/26/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts